Skip to main content
logo
Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
4.820
+0.070 (1.47%)
At close: Oct 7, 2026, 4:00 PM EDT
4.710
-0.110 (-2.28%)
Pre-market: Oct 8, 2026, 4:46 AM EDT

Sionna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2181,836---
Market Cap Growth
-83.55%----
Enterprise Value
-421,520---
Last Close Price
4.8241.14---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.825.98---
P/TBV Ratio
0.825.98---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.030.030.060.31-
Net Debt / Equity Ratio
-0.98-0.98-0.95-0.82-1.04
Net Debt / EBITDA Ratio
2.393.422.270.562.00
Net Debt / FCF Ratio
3.414.523.000.632.18
Quick Ratio
19.5720.1414.164.7910.01
Current Ratio
20.0520.6114.494.8810.16
Return on Equity (ROE)
-32.34%-31.79%-61.44%-83.45%-
Return on Assets (ROA)
-21.54%-21.74%-37.10%-45.16%-
Return on Capital Employed (ROCE)
-40.20%-28.30%-40.20%-114.60%-52.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-44.69%-4.10%---
FCF Yield
-34.97%-3.63%---
Buyback Yield / Dilution
-124.56%-935.60%-31.56%-13.80%-
SEC Filings: 10-K · 10-Q